Rui Kang Pharmaceutical Group Investments Ltd ($8037) - buy or sell? Stock discussion, ideas, forum

Rui Kang Pharmaceutical Group Investments Ltd

Rui Kang Pharmaceutical Group Investments Limited is an investment holding company.

Industry: Cosmetics/Personal Care

Ticker	Exchange	ISIN	Name
$8381	HKEx GEM	BMG7713H1328	Code: 8381
$8037	HKEx GEM	BMG7713H1245	Code: 8037

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 8037 stock

Share your investment idea or question on Rui Kang Pharmaceutical Group Investments Ltd stock:

Latest twits on Rui Kang Pharmaceutical Group Investments Ltd (8037)

No twits yet. Be the first to post!

Have a question about 8037? Ask and other investors will be eager to help you.

Have an idea about 8037? Share it with other investors.

Rui Kang Pharmaceutical Group Investments Ltd news

16/03/2017 Rui Kang Pharmaceutical Group Investments Ltd Net Income surged on 417% and Revenue jumped on 129%

15/03/2016 Rui Kang Pharmaceutical Group Investments Ltd reports 157% Net Income growth and 117% Revenue growth

Rui Kang Pharmaceutical Group Investments Ltd stock price chart

Rui Kang Pharmaceutical Group Investments Ltd financials

mln. HKD	FY2010	FY2011	FY2012

Revenue	123.8	131.2	124.7
EBITDA	16.817	22.438	11.897
Net income	9.230	4.040	4.781
CAPEX	4.805	6.069	8.043
Debt	0.000	0.000	0.000
Cash	5.938	34.319	22.901

Rui Kang Pharmaceutical Group Investments Ltd news

About Rui Kang Pharmaceutical Group Investments Ltd

Rui Kang Pharmaceutical Group Investments Limited is an investment holding company. The Company's subsidiaries manufacture, research, develop, sell, and distribute cosmetics and pharmaceutical products in China and Hong Kong. The Company is also engaged in the trading of securities.